We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Light-Induced Immunoassay Selectively Detects Coronavirus Spike Proteins In 5 Minutes

By LabMedica International staff writers
Posted on 19 Sep 2024

Like moths drawn to a flame, microbes can also be influenced by light. More...

Using this principle, researchers have developed a method to quickly detect viruses using only a small sample.

Scientists at Osaka Metropolitan University's Research Institute for Light-induced Acceleration System (RILACS) have developed a light-induced immunoassay for virus detection. By applying laser irradiation for less than a minute, they used a nanoparticle-imprinted plasmonic substrate with nanobowl structures (each 500 nm in diameter) coated with antibodies for the spike proteins of the novel coronavirus. A low-power 5-milliwatt laser, similar to commercial laser pointers, was able to form bubbles on the biochip that attracted virus-mimicking nanoparticles, speeding up the selective detection of these particles.

The process works because light-induced convection causes the nanoparticles to move and gather at a stagnant region between the substrate surface and the bottom of the bubble, meaning a high particle concentration isn't necessary. The entire procedure—from coating the substrate to detecting the virus—can be completed in under 5 minutes, as reported in the journal npj Biosensing.

“This study shows that we can shorten the cumbersome antibody coating process and perform rapid and highly sensitive protein detection,” said OMU Professor Takuya Iida, the director of RILACS. “We believe our findings can contribute to the early diagnosis of not only the novel coronavirus, but possibly also various infectious diseases, cancer, even dementia.”

Related Links:
RILACS


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The study identified a distinct immune signature associated with treatment-resistant myasthenia gravis (Dodd, Katherine C. et al., Med (2026). DOI: 10.1016/j.medj.2025.100987)

Immune Signature Identified in Treatment-Resistant Myasthenia Gravis

Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.